These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 19735884)
61. Investigation of the geometric accuracy of proton beam irradiation in the liver. Fukumitsu N; Hashimoto T; Okumura T; Mizumoto M; Tohno E; Fukuda K; Abei M; Sakae T; Sakurai H Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):826-33. PubMed ID: 21236603 [TBL] [Abstract][Full Text] [Related]
62. Short-lived positron emitters in beam-on PET imaging during proton therapy. Dendooven P; Buitenhuis HJ; Diblen F; Heeres PN; Biegun AK; Fiedler F; van Goethem MJ; van der Graaf ER; Brandenburg S Phys Med Biol; 2015 Dec; 60(23):8923-47. PubMed ID: 26539812 [TBL] [Abstract][Full Text] [Related]
63. Extension and validation of an analytical model for in vivo PET verification of proton therapy--a phantom and clinical study. Attanasi F; Knopf A; Parodi K; Paganetti H; Bortfeld T; Rosso V; Del Guerra A Phys Med Biol; 2011 Aug; 56(16):5079-98. PubMed ID: 21775794 [TBL] [Abstract][Full Text] [Related]
64. Beam-on imaging of short-lived positron emitters during proton therapy. Buitenhuis HJT; Diblen F; Brzezinski KW; Brandenburg S; Dendooven P Phys Med Biol; 2017 Jun; 62(12):4654-4672. PubMed ID: 28379155 [TBL] [Abstract][Full Text] [Related]
65. Bladder and rectum volume estimations using CT and stereology. Mazonakis M; Damilakis J; Varveris H Comput Med Imaging Graph; 1998; 22(3):195-201. PubMed ID: 9740037 [TBL] [Abstract][Full Text] [Related]
66. Microscopic gold particle-based fiducial markers for proton therapy of prostate cancer. Lim YK; Kwak J; Kim DW; Shin D; Yoon M; Park S; Kim JS; Ahn SH; Shin J; Lee SB; Park SY; Pyo HR; Kim DY; Cho KH Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1609-16. PubMed ID: 19616746 [TBL] [Abstract][Full Text] [Related]
67. Carbon ions beam therapy monitoring with the INSIDE in-beam PET. Pennazio F; Battistoni G; Bisogni MG; Camarlinghi N; Ferrari A; Ferrero V; Fiorina E; Morrocchi M; Sala P; Sportelli G; Wheadon R; Cerello P Phys Med Biol; 2018 Jul; 63(14):145018. PubMed ID: 29873299 [TBL] [Abstract][Full Text] [Related]
68. Verification of beam delivery using fibrosis after proton beam irradiation to the lung tumor. Fukumitsu N; Oshiro Y; Hashimoto T; Okumura T; Mizumoto M; Moritake T; Tsuboi K; Sakae T; Sakurai H Lung Cancer; 2012 Jul; 77(1):83-8. PubMed ID: 22281073 [TBL] [Abstract][Full Text] [Related]
69. Experimental verification of the utility of positron emitter nuclei generated by photonuclear reactions for X-ray beam monitoring in a phantom. Nishio T; Inaniwa T; Inoue K; Miyatake A; Nakagawa K; Yoda K; Ogino T Radiat Med; 2007 Dec; 25(10):516-22. PubMed ID: 18085402 [TBL] [Abstract][Full Text] [Related]
70. The first PET glimpse of a proton FLASH beam. Abouzahr F; Cesar JP; Crespo P; Gajda M; Hu Z; Kaye W; Klein K; Kuo AS; Majewski S; Mawlawi O; Morozov A; Ojha A; Poenisch F; Polf JC; Proga M; Sahoo N; Seco J; Takaoka T; Tavernier S; Titt U; Wang X; Zhu XR; Lang K Phys Med Biol; 2023 Jun; 68(12):. PubMed ID: 37141903 [TBL] [Abstract][Full Text] [Related]
71. Radioactivity and Space Range of Ultra-Low-Activity for Zhang F; Zhang J; Lu Y; Sheng Y; Sun Y; Zhang J; Cheng J; Zhou R Front Public Health; 2021; 9():771017. PubMed ID: 34938708 [No Abstract] [Full Text] [Related]
72. [Value of positron emission tomography and computer tomography (PET/CT) for urologic malignancies]. Boujelbene N; Prior JO; Boubaker A; Azria D; Schaffer M; Gez E; Jichlinski P; Meuwly JY; Mirimanoff RO; Ozsahin M; Zouhair A Cancer Radiother; 2011 Jul; 15(4):307-15. PubMed ID: 21507695 [TBL] [Abstract][Full Text] [Related]
73. The production of positron emitters with millisecond half-life during helium beam radiotherapy. Ozoemelam I; van der Graaf E; Brandenburg S; Dendooven P Phys Med Biol; 2019 Dec; 64(23):235012. PubMed ID: 31658450 [TBL] [Abstract][Full Text] [Related]
74. Measurement of the Zapien-Campos B; Ahmadi Ganjeh Z; Both S; Dendooven P Phys Med Biol; 2024 Mar; 69(7):. PubMed ID: 38382103 [No Abstract] [Full Text] [Related]
75. A deconvolution approach for PET-based dose reconstruction in proton radiotherapy. Remmele S; Hesser J; Paganetti H; Bortfeld T Phys Med Biol; 2011 Dec; 56(23):7601-19. PubMed ID: 22086216 [TBL] [Abstract][Full Text] [Related]
76. [Individual control of urine volume to improve stability of bladder volume in radiotherapy of urinary tumor]. Wang H; Jiang SK; Peng R; Huang Y; Wang MQ; Wang JJ; Liu C; Zhang F; Ma LL Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Aug; 52(4):688-691. PubMed ID: 32773802 [TBL] [Abstract][Full Text] [Related]
77. Usefulness of positron-emission tomographic images after proton therapy. Hishikawa Y; Kagawa K; Murakami M; Sakai H; Akagi T; Abe M Int J Radiat Oncol Biol Phys; 2002 Aug; 53(5):1388-91. PubMed ID: 12128141 [TBL] [Abstract][Full Text] [Related]
78. Monitoring of patients treated with particle therapy using positron-emission-tomography (PET): the MIRANDA study. Combs SE; Bauer J; Unholtz D; Kurz C; Welzel T; Habermehl D; Haberer T; Debus J; Parodi K BMC Cancer; 2012 Apr; 12():133. PubMed ID: 22471947 [TBL] [Abstract][Full Text] [Related]
79. Comparing the biological washout of β+-activity induced in mice brain after 12C-ion and proton irradiation. Ammar C; Frey K; Bauer J; Melzig C; Chiblak S; Hildebrandt M; Unholtz D; Kurz C; Brons S; Debus J; Abdollahi A; Parodi K Phys Med Biol; 2014 Dec; 59(23):7229-44. PubMed ID: 25383509 [TBL] [Abstract][Full Text] [Related]
80. Feasibility of proton-activated implantable markers for proton range verification using PET. Cho J; Ibbott G; Gillin M; Gonzalez-Lepera C; Titt U; Paganetti H; Kerr M; Mawlawi O Phys Med Biol; 2013 Nov; 58(21):7497-512. PubMed ID: 24099853 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]